1.Brown, S, Inskip, H, Barraclough, B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000;177:212–217.
2.Hennekens, CH, Hennekens, AR, Hollar, D, Casey, DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005;150:1115–1121.
3.Curkendall, SM, Mo, J, Glasser, DB, Rose Stang, M, Jones, JK. Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. J Clin Psychiatry 2004;65:715–720.
4.Carpeggiani, C, Emdin, M, Bonaguidi, Fet al. Personality traits and heart rate variability predict long-term cardiac mortality after myocardial infarction. Eur Heart J 2005;26:1612–1617.
5.Smith, LL, Kukielka, M, Billman, GE. Heart rate recovery after exercise: a predictor of ventricular fibrillation susceptibility after myocardial infarction. Am J Physiol Heart Circ Physiol 2005;288:H1763–H1769.
6.Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996;93:1043–1065.
7.Boettger, S, Hoyer, D, Falkenhahn, K, Kaatz, M, Yeragani, VK, Bar, KJ. Altered diurnal autonomic variation and reduced vagal information flow in acute schizophrenia. Clin Neurophysiol 2006;117:2715–2722.
8.Galuszka, J, Opavsky, J, Lukl, J, Stejskal, P, Zapletalova, J, Salinger, J. Short-term spectral analysis of heart rate variability during supine-standing-supine test in patients with paroxysmal atrial fibrillation. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2004;148:63–67.
9.Kojecky, V, Bernatek, J, Horowitz, M, Zemek, S, Bakala, J, Hep, A. Prevalence and determinants of delayed gastric emptying in hospitalised type 2 diabetic patients. World J Gastroenterol 2008;14:1564–1569.
10.Boulton, AJ, Vinik, AI, Arezzo, JCet al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005;28:956–962.
11.Okada, T, Toichi, M, Sakihama, M. Influences of an anticholinergic antiparkinsonian drug, parkinsonism, and psychotic symptoms on cardiac autonomic function in schizophrenia. J Clin Psychopharmacol 2003;23:441–447.
12.Toichi, M, Kubota, Y, Murai, Tet al. The influence of psychotic states on the autonomic nervous system in schizophrenia. Int J Psychophysiol 1999;31:147–154.
13.Rechlin, T, Claus, D, Weis, M. Heart rate variability in schizophrenic patients and changes of autonomic heart rate parameters during treatment with clozapine. Biol Psychiatry 1994;35:888–892.
14.Cohen, H, Matar, MA, Kaplan, Z, Kotler, M. Power spectral analysis of heart rate variability in psychiatry. Psychother Psychosom 1999;68:59–66.
15.Hennessy, S, Bilker, WB, Knauss, JSet al. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ 2002;325:1070.
16.Birkhofer, A, Geissendoerfer, J, Alger, Pet al. The deceleration capacity – a new measure of heart rate variability evaluated in patients with schizophrenia and antipsychotic treatment. Eur Psychiatry 2013;28:81–86.
17.Su, KP, Shen, WW, Chuang, CL, Chen, KP, Chen, CC. A pilot cross-over design study on QTc interval prolongation associated with sulpiride and haloperidol. Schizophr Res 2003;59:93–94.
18.Valkonen-Korhonen, M, Tarvainen, MP, Ranta-Aho, Pet al. Heart rate variability in acute psychosis. Psychophysiology 2003;40:716–726.
19.Bär, KJ, Letzsch, A, Jochum, T, Wagner, G, Greiner, W, Sauer, H. Loss of efferent vagal activity in acute schizophrenia. J Psychiatr Res 2005;39:519–527.
20.Chang, HA, Lu, RB, Lin, WWet al. Lack of association between dopamine D3 receptor Ser9Gly polymorphism and schizophrenia in Han Chinese. Acta Neuropsychiatrica 2007;19:344–350.
21.Chang, HA, Lu, RB, Shy, MJ, Chang, CC, Lee, MS, Huang, SY. Brain-derived neurotrophic factor Val66Met polymorphism: association with psychopathological symptoms of schizophrenia? J Neuropsychiatry Clin Neurosci 2009;21:30–37.
22.Chang, HA, Chang, CC, Chen, CLet al. Major depression is associated with cardiac autonomic dysregulation. Acta Neuropsychiatrica 2012;24:318–327.
23.Chang, HA, Chang, CC, Chen, CLet al. Heart rate variability in patients with fully remitted major depressive disorder. Acta Neuropsychiatrica 2012. DOI:10.1111/j.1601-5215.2012.00658.x
24.Endicott, J, Spitzer, RL. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978;35:837–844.
25.Kay, SR, Fiszbein, A, Opler, LA. The Positive And Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261–276.
26.Kuo, TB, Lin, T, Yang, CC, Li, CL, Chen, CF, Chou, P. Effect of aging on gender differences in neural control of heart rate. Am J Physiol 1999;277:H2233–H2239.
27.Liu, CC, Kuo, TB, Yang, CC. Effects of estrogen on gender-related autonomic differences in humans. Am J Physiol Heart Circ Physiol 2003;285:H2188–H2193.
28.Rottenberg, J. Cardiac vagal control in depression: a critical analysis. Biol Psychol 2007;74:200–211.
29.Li, Z, Snieder, H, Su, Set al. A longitudinal study in youth of heart rate variability at rest and in response to stress. Int J Psychophysiol 2009;73:212–217.
30.Martin, LA, Doster, JA, Critelli, JWet al. Ethnicity and type D personality as predictors of heart rate variability. Int J Psychophysiol 2010;76:118–121.
31.Agelink, MW, Majewski, T, Wurthmann, Cet al. Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine. J Clin Psychopharmacol 2001;21:8–13.
32.Chang, JS, Yoo, CS, Yi, SHet al. Changes in heart rate dynamics of patients with schizophrenia treated with risperidone. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:924–929.
33.Bär, KJ, Wernich, K, Boettger, Set al. Relationship between cardiovagal modulation and psychotic state in patients with paranoid schizophrenia. Psychiatry Res 2008;157:255–257.
34.Malaspina, D, Bruder, G, Dalack, GWet al. Diminished cardiac vagal tone in schizophrenia: associations to brain laterality and age of onset. Biol Psychiatry 1997;41:612–617.
35.Pomeranz, B, Macaulay, RJ, Caudill, MAet al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985;248:H151–H153.
36.Sloan, RP, McCreath, H, Tracey, KJ, Sidney, S, Liu, K, Seeman, T. RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med 2007;13:178–184.
37.Moak, JP, Goldstein, DS, Eldadah, BAet al. Supine low-frequency power of heart rate variability reflects baroreflex function, not cardiac sympathetic innervation. Heart Rhythm 2007;4:1523–1529.
38.Bar, KJ, Koschke, M, Berger, Set al. Influence of olanzapine on QT variability and complexity measures of heart rate in patients with schizophrenia. J Clin Psychopharmacol 2008;28:694–698.
39.Jindal, R, Mackenzie, EM, Baker, GB, Yeragani, VK. Cardiac risk and schizophrenia. J Psychiatry Neurosci 2005;30:393–395.
40.Lombardi, F. Clinical implications of present physiological understanding of HRV components. Card Electrophysiol Rev 2002;6:245–249.
41.Mackowiak, M, Dudys, D, Chocyk, A, Wedzony, K. Repeated risperidone treatment increases the expression of NCAM and PSA-NCAM protein in the rat medial prefrontal cortex. Eur Neuropsychopharmacol 2009;19:125–137.
42.Mcnamara, RK, Able, JA, Jandacek, R, Rider, T, TSO, P. Chronic risperidone treatment preferentially increases rat erythrocyte and prefrontal cortex omega-3 fatty acid composition: evidence for augmented biosynthesis. Schizophr Res 2009;107:150–157.
43.Jindal, RD, Keshavan, MS, Eklund, K, Stevens, A, Montrose, DM, Yeragani, VK. Beat-to-beat heart rate and QT interval variability in first episode neuroleptic-naive psychosis. Schizophr Res 2009;113:176–180.
44.Williams, LM, Das, P, Harris, AWet al. Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am J Psychiatry 2004;161:480–489.
45.Wong, SW, Masse, N, Kimmerly, DS, Menon, RS, Shoemaker, JK. Ventral medial prefrontal cortex and cardiovagal control in conscious humans. Neuroimage 2007;35:698–708.
46.Ziegler, G, Dahnke, R, Yeragani, VK, Bar, KJ. The relation of ventromedial prefrontal cortex activity and heart rate fluctuations at rest. Eur J Neurosci 2009;30:2205–2210.
47.Jenkins, J, Shajahan, PM, Lappin, JM, Ebmeier, KP. Right and left prefrontal transcranial magnetic stimulation at 1 Hz does not affect mood in healthy volunteers. BMC Psychiatry 2002;2:1.
48.Grossheinrich, N, Rau, A, Pogarell, Oet al. Theta burst stimulation of the prefrontal cortex: safety and impact on cognition, mood, and resting electroencephalogram. Biol Psychiatry 2009;65:778–784.
49.Appleby, L, Thomas, S, Ferrier, N, Lewis, G, Shaw, J, Amos, T. Sudden unexplained death in psychiatric in-patients. Br J Psychiatry 2000;176:405–406.
50.Ray, WA, Chung, CP, Murray, KT, Hall, K, Stein, CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009;360:225–235.
51.Cohen, H, Loewenthal, U, Matar, M, Kotler, M. Association of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication. Br J Psychiatry 2001;179:167–171.
52.Silke, B, Campbell, C, King, DJ. The potential cardiotoxicity of antipsychotic drugs as assessed by heart rate variability. J Psychopharmacol 2002;16:355–360.
53.Wang, YC, Yang, CC, Bai, YM, Kuo, TB. Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine. 3-month follow-up. Neuropsychobiology 2008;57:200–205.
54.Bar, KJ, Boettger, MK, Koschke, Met al. Non-linear complexity measures of heart rate variability in acute schizophrenia. Clin Neurophysiol 2007;118:2009–2015.
55.Bar, KJ, Boettger, MK, Schulz, Set al. The interaction between pupil function and cardiovascular regulation in patients with acute schizophrenia. Clin Neurophysiol 2008;119:2209–2213.
56.Sato, N, Miyake, S, Akatsu, J, Kumashiro, M. Power spectral analysis of heart rate variability in healthy young women during the normal menstrual cycle. Psychosom Med 1995;57:331–335.